Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G04 UROLOGICALS
G04B UROLOGICALS
G04BE Drugs used in erectile dysfunction
G04BE07 Apomorphine
D02004 Apomorphine hydrochloride (USP) <JP/US>
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BC Dopamine agonists
N04BC07 Apomorphine
D02004 Apomorphine hydrochloride (USP) <JP/US>
USP drug classification [BR:br08302]
Antiparkinson Agents
Dopamine Agonists
Apomorphine
D02004 Apomorphine hydrochloride (USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
116 Antiparkinsonian agents
1169 Others
D02004 Apomorphine hydrochloride (USP); Apomorphine hydrochloride hydrate (JAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00486 Apomorphine
D02004 Apomorphine hydrochloride
DG01967 Antiparkinson agent
DG00486 Apomorphine
D02004 Apomorphine hydrochloride
Drug classes [BR:br08332]
Neuropsychiatric agent
DG01967 Antiparkinson agent
D02004 Apomorphine hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D02004 Apomorphine hydrochloride (USP) <JP/US>
DRD2
D02004 Apomorphine hydrochloride (USP) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02004
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02004
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02004
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00486 Apomorphine
DG01967 Antiparkinson agent
DG00486 Apomorphine